Subject of the day
GETI-B.ST
Getinge AB (publ) provides products and solutions for operating rooms, intensive-care units, and sterilization departments in Sweden and internationally. The company operates through Acute Care Therapies, Life Science, and Surgical Workflows segments. It offers extracorporeal membrane oxygenation, mechanical ventilation, advanced patient monitoring, ICU infrastructure equipment, and drainage solutions. In addition, the company provides surgical perfusion, endoscopic vessel harvesting, intra-aortic balloon counterpulsation, vascular and cardiothoracic surgery equipment, peripheral stenting, OEM solutions, and beating heart surgery equipment; and operating room equipment, anesthesia, advanced patient monitoring, and operating room integration solutions. Further, it offers pre-cleaning, cleaning and disinfection, sterilization, consumables, endoscope reprocessing, and sterile supply management solutions; connected medical devices, and patient flow management; and low temperature sterilization, biocontainment in vaccine production, terminal sterilization, sterile isolation technology, cleaning and sterilization, aseptic transfer, and large-scale cultivation. Additionally, the company provides bioreactor preparation solution, bioprocess development and optimization, labware cleaning and sterilization, biocontainment, and vivarium. It offers its products through a network of sales companies, as well as through agents and distributors in the Americas, Europe, the Middle East, Africa, and the Asia and Pacific. Getinge AB (publ) was founded in 1904 and is headquartered in Gothenburg, Sweden.
| Line | Mar 2025 | Jun 2025 | Dec 2025 | Mar 2026 |
|---|---|---|---|---|
| Revenue | $8.32B | $8.24B | $10.19B | $7.44B |
| Gross profit | $4.09B | $3.94B | $4.80B | $3.61B |
| Operating income | $896.00M | $895.00M | $1.41B | $738.00M |
| Net income | $300.00M | $524.00M | $868.00M | $401.00M |
| Diluted EPS | 1.10 | 1.92 | 3.19 | 1.47 |
| Free cash flow | $157.00M | $506.00M | $1.18B | $838.00M |
| CapEx | -$313.00M | -$335.00M | -$370.00M | -$268.00M |
$239.90
▲ +0.60 (+0.3%)
| 52w hi | $239.90 |
|---|---|
| 52w lo | $176.27 |
| Vol | 437.56K |
| As of | Aug 13 |
Our score +0.11
| Short | -0.10 |
|---|---|
| Medium | +0.22 |
| Long | +0.30 |
computed 2026-08-13
Getinge AB (publ)
Healthcare · Medical Devices
| Market cap | $65.34B |
|---|---|
| Enterprise value | $74.28B |
| Trailing P/E | 24.38x |
| Forward P/E | 21.93x |
| EV / EBITDA | 12.61x |
| P / S (ttm) | 1.91x |
| Profit margin | 7.8% |
| Return on equity | 8.9% |
| Revenue growth | +1.7% |
| Earnings growth | +60.5% |
| Debt / equity | 35.81 |
| Beta vs SPX | 0.16 |
|---|---|
| Corr SPX | 0.10 |
| Annual vol | 27.2% |
| Annual ret | +11.9% |
| Sharpe | 0.44 |
| Max DD | -28.5% |
Window: 504 trading days (490 obs)
| Layer | Raw | Contribution |
|---|---|---|
| Fundamental | +0.24 | |
| Sector | +0.12 | |
| Technical | +0.00 | |
| Earnings | +0.00 | |
| Sentiment | +0.00 |
macro × 1.00 · 2026-08-13
| Date | Open | High | Low | Close | Vol |
|---|---|---|---|---|---|
| Aug 13 | $239.30 | $241.60 | $239.00 | $239.90 | 437.56K |
| Aug 12 | $239.00 | $241.30 | $236.80 | $239.30 | 249.44K |
| Aug 11 | $238.70 | $239.80 | $237.20 | $239.00 | 428.50K |
| Aug 10 | $238.00 | $239.20 | $235.20 | $239.20 | 341.06K |
| Aug 7 | $237.30 | $239.40 | $237.00 | $237.00 | 347.16K |